Robeco Institutional Asset Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-228,220
| Closed | -$6.64M | – | 979 |
|
|
2018
Q4 | $6.64M | Hold |
228,220
| – | – | 0.03% | 487 |
|
|
2018
Q3 | $10.5M | Hold |
228,220
| – | – | 0.04% | 425 |
|
|
2018
Q2 | $8.53M | Hold |
228,220
| – | – | 0.04% | 436 |
|
|
2018
Q1 | $6.74M | Buy |
228,220
+54,122
| +31% | +$1.6M | 0.03% | 476 |
|
|
2017
Q4 | $5.98M | Buy |
+174,098
| New | +$5.98M | 0.03% | 464 |
|
|
2014
Q3 | – | Sell |
-78,188
| Closed | -$3.04M | – | 776 |
|
|
2014
Q2 | $3.04M | Hold |
78,188
| – | – | 0.02% | 376 |
|
|
2014
Q1 | $2.67M | Hold |
78,188
| – | – | 0.02% | 375 |
|
|
2013
Q4 | $1.64M | Hold |
78,188
| – | – | 0.01% | 387 |
|
|
2013
Q3 | $1.84M | Hold |
78,188
| – | – | 0.02% | 386 |
|
|
2013
Q2 | $2.1M | Buy |
+78,188
| New | +$2.1M | 0.02% | 367 |
|